menu
    • menu

    Company profile for Innovative Molecules

    NEW Drugs in Dev: 2
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Innovative Molecules is a start-up biotechnology company based within the New Jersey BioScience Center at North Brunswick (the NJEDA State Incubator). We are focused on the discovery and development of novel small molecule medicines for the treatment of cancer, metabolic-, and inflammatory-diseases, all areas with significant unmet medical need. Innovative Molecules is combining the power of established pharmacotherapeutic or ...
    Innovative Molecules is a start-up biotechnology company based within the New Jersey BioScience Center at North Brunswick (the NJEDA State Incubator). We are focused on the discovery and development of novel small molecule medicines for the treatment of cancer, metabolic-, and inflammatory-diseases, all areas with significant unmet medical need. Innovative Molecules is combining the power of established pharmacotherapeutic or metabolic activity inherent to many natural or proven compounds with an innovative approach toward improving kinetic and efficacy parameters.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Innovative MoleculesGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Dachauer Str. 65 80335, München​, Bayer
    Telephone
    Telephone
    +1-732-253-7770
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.innovativemolecules.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/innovative-molecules/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Innovative Molecules Advances Adibelivir to Phase 2
    Innovative Molecules Advances Adibelivir to Phase 2

    29 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovative-molecules-announces-completion-of-phase-1-program-and-advancement-to-phase-2-for-oral-adibelivir-302673916.html

    PR NEWSWIRE
    29 Jan 2026
    Share Share
    Alfasigma Acquires Exclusive Rights To Parenteral Adibelivir
    Alfasigma Acquires Exclusive Rights To Parenteral Adibelivir

    13 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-13/alfasigma-secures-exclusive-rights-from-innovative-molecules-to-parenteral-adibelivir-for-treatment-of-hsv-encephalitis-an-ultra-rare-disease

    PHARMIWEB
    13 Jan 2026
    Share Share
    Innovative Molecules Finishes Phase 1b Trial Enrollment
    Innovative Molecules Finishes Phase 1b Trial Enrollment

    16 Jun 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovative-molecules-completes-enrollment-of-phase-1b-clinical-trial-of-im-250-302482332.html

    PR NEWSWIRE
    16 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search